Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Grade 1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01670266
What this trial is testing

Single and Multiple Dose Escalation and Two-sequence Crossover Study of ONO-9054 in Patients With Ocular Hypertension or Mild Open-angle Glaucoma

Who this might be right for
Ocular Hypertension (OHT)Mild Open Angle-glaucoma (OAG)
Ono Pharma USA Inc 60
Post-approval studies (Phase 4)UnknownNCT06044103
What this trial is testing

Patient-controlled Sedation During Repair of Obstetric Perineal Lacerations

Who this might be right for
PainPatient Satisfaction
Marie Blomberg 80
Testing effectiveness (Phase 2)Study completedNCT00736996
What this trial is testing

Pioglitazone Or Exercise to Treat Mild Cognitive Impairment (MCI)

Who this might be right for
Mild Cognitive Impairment
University of Colorado, Denver 78
Early research (Phase 1)Study completedNCT00063973
What this trial is testing

Cilengitide in Treating Children With Refractory Primary Brain Tumors

Who this might be right for
Childhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus TumorChildhood Craniopharyngioma+23 more
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT01601470
What this trial is testing

Evaluation of Drug-drug Interaction Between LCZ696 and Sildenafil in Subjects With Mild to Moderate Hypertension

Who this might be right for
Mild to Moderate Hypertension
Novartis Pharmaceuticals 28
Not applicableLooking for participantsNCT04114994
What this trial is testing

Longitudinal Cognitive Assessment by BoCA

Who this might be right for
Alzheimer DiseaseMild Cognitive ImpairmentVascular Dementia+4 more
Alzheimer's Light LLC 10,000
Post-approval studies (Phase 4)Study completedNCT02379156
What this trial is testing

Thermoregulation and Cognition During Cool Ambient Exposure in Tetraplegia

Who this might be right for
TetraplegiaHypothermiaMild Cognitive Impairment
James J. Peters Veterans Affairs Medical Center 30
Not applicableUnknownNCT06306651
What this trial is testing

High Flow Nasal Cannula and Conventional Oxygen Therapy in the Postoperative Management of Patients With Mild to Moderate Obstructive Sleep Apnea

Who this might be right for
High Flow Nasal CannulaObstructive Sleep Apnea
Ain Shams University 60
Not applicableLooking for participantsNCT04543253
What this trial is testing

Recovery From Cushing Syndrome and Mild Autonomous Cortisol Secretion (MACS)

Who this might be right for
Cushing Syndrome
Mayo Clinic 700
Early research (Phase 1)Study completedNCT06529796
What this trial is testing

Evaluation of the Pharmacokinetics and Safety of Inaxaplin in Participants With Mild or Moderate Hepatic Impairment

Who this might be right for
Focal Segmental Glomerulosclerosis (FSGS)
Vertex Pharmaceuticals Incorporated 36
Not applicableLooking for participantsNCT07146373
What this trial is testing

Effect of Inspiratory Muscle Training in Cognition

Who this might be right for
Mild Cognitive Impairment (MCI)
University of West Attica 76
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07567469
What this trial is testing

A Safety and Efficacy Study of Combined Fianlimab + Cemiplimab in Children and Young Adults With Recurrent or Progressive High-Grade Glioma or Posterior Fossa-A Ependymoma

Who this might be right for
High-Grade Glioma (HGG)Posterior Fossa-A Ependymoma
Regeneron Pharmaceuticals 120
Testing effectiveness (Phase 2)Study completedNCT01303783
What this trial is testing

Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension

Who this might be right for
Hypertension, Essential
Bayer 1,381
Testing effectiveness (Phase 2)Study completedNCT04399356
What this trial is testing

Niclosamide for Mild to Moderate COVID-19

Who this might be right for
COVID-19
Tufts Medical Center 73
Testing effectiveness (Phase 2)Active Not RecruitingNCT04404088
What this trial is testing

Acalabrutinib, Lenalidomide, and Rituximab for the Treatment of CD20 Positive Stage III-IV, Grade 1-3a Follicular Lymphoma

Who this might be right for
Ann Arbor Stage III Grade 1 Follicular LymphomaAnn Arbor Stage III Grade 2 Follicular LymphomaAnn Arbor Stage III Grade 3 Follicular Lymphoma+4 more
M.D. Anderson Cancer Center 60
Not applicableStudy completedNCT04062422
What this trial is testing

Ulna Length in Black Children

Who this might be right for
Ulna Length in Otherwise Healthy Children (With the Exception of Mild to Moderate Asthma)
Assistance Publique - Hôpitaux de Paris 350
Post-approval studies (Phase 4)UnknownNCT01220622
What this trial is testing

Efficacy and Safety Study of Nimodipine to Prevent Mild Cognitive Impairment After Acute Ischemic Strokes

Who this might be right for
StrokeMild Cognitive Impairment
Ministry of Science and Technology of the People´s Republic of China 656
Not applicableStudy completedNCT02388451
What this trial is testing

The Benefits of the Use of the Feuerstein Cognitive Training Method on Cognitive Function in Community-dwelling Older Patients With Mild Cognitive Impairment: a Pilot Study

Who this might be right for
Mild Cognitive Impairment
Meir Medical Center 11
Testing effectiveness (Phase 2)Ended earlyNCT02249351
What this trial is testing

Efficacy and Safety of Talsaclidine (Free Base) in Patients With Mild to Moderate Dementia of Alzheimer Type

Who this might be right for
Alzheimer Disease
Boehringer Ingelheim 54
Not applicableStudy completedNCT05756270
What this trial is testing

Clinical Applicability of pCASL as a Substitute for FDG-PET in MCI and SCD Patients

Who this might be right for
Mild Cognitive ImpairmentSubjective Cognitive Decline
University of Milano Bicocca 150
Next Page